Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
NLRC4 is also known as IPAF, NOD27, and CLR16.1. The NLRC4 protein is mainly expressed in hematopoietic tissues and cells, and includes an N-terminal CARD domain, an intermediate NBD domain, and a C-terminal LRR domain. Since it has a CARD domain, NLRC4 can directly bind to the CARD domain of pro-caspase-1, so its own activation can be independent of the presence of the adaptor protein ASC. However, studies have shown that when ASC is absent, both caspase-1 activation and IL-1β secretion are attenuated, indicating that ASC is important for the activation of NLRC4 inflammatory bodies. When the LRR domain is deleted, NLRC4 directly activates Caspase-1, suggesting that the LRR domain may play a role in inhibiting the activation of NLRC4 inflammatory bodies.
The Mechanism of NLRC4
NLRC4 inflammasome mainly plays a role in resisting external bacterial infection. When the organism is infected with bacteria such as Salmonella, Legionella, Pseudomonas, and Shigella, the assembly of NLRC4 inflammasome in macrophages plays a key role in the activation of caspase-1. Studies have shown that bacteria activate inflammatory bodies because of the presence of flagellin. The type III secretion system (T3SS) and the type IV secretion system (T4SS) are molecular needle-like structures that can inject effector proteins into the cytoplasm of host cells and play an important role in bacterial infection. Flagellin can be injected into host cells via a type III secretion system (such as Salmonella) or a type 4 secretion system (such as Legionella pneumophila) to activate NLRC4 inflammatory bodies. In order to sense the flagellin of different bacteria, the NLRC4 protein must coordinate with the member of the NLR family, NAIP (neuronal apoptosis inhibitor protein), to activate the NLRC4 inflammatory body. NAIP5 is able to sense the C-terminal region of Legionella pneumophila flagellin and activate NLRC4 inflammatory bodies, whereas Salmonella activates NLRC4 inflammatory bodies independent of NAIP5.
Figure 1. NLRC4 inflammasome activation leads to diverse downstream effects. (Hafner-Bratkovi., et al. 2017)
The NLRC4 inflammatory body regulates the host immune response by regulating the secretion of IL-1β and IL-18 inflammatory factors, bacterial degradation, and Caspase-1 dependent cell apoptosis. When infected with acute Salmonella, neutrophil NLRC4 inflammatory bodies assemble and promote IL-1β secretion, but do not trigger cell sagging. After infection of the host with Legionella pneumophila, it can only replicate in specific vacuoles of macrophages. NLRC4-dependent activation of Caspase-1 promotes the binding of bacterial-containing vacuoles to lytic bodies and inhibits the replication of Legionella pneumophila. However, its inhibition of Legionella pneumophila growth is dependent on the flagellin on the surface of Legionella pneumophila and the activity of Caspase-7 in the host cell, independent of the secretion of IL-1β and IL-18.
NLRC4 and Disease
NLRC4 has an important link to human inflammatory responses. The autoinflammatory response is a systemic or organ-specific inflammatory, different from infection, tumor, or antigen-specific autoimmunity. The inflammatory response is initially seen in monogenic diseases and is characterized by spontaneous or progressively increased inflammatory activity. NLRC4-related infantile enterocolitis differs from other early onset inflammatory bowel disease (VEO-IBD). Known NLRC4-related infant Inflammatory reactions to enterocolitis extend the entire gut. If the patient survives in infancy, the final symptoms will disappear, but there is still an increase in serum IL-18 levels. The inflammatory response of the kidney is an immune response to infectious or non-infectious activators. The expression of renal tubular and interstitial NLRC4 was significantly increased in patients with diabetic nephropathy and was positively correlated with the degree of tubulointerstitial lesions. The progression of nephropathy in NLRC4-/- mice was significantly delayed. It is speculated that NLRC4 may also play an important role in kidney disease.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.